| 前收市價 | 51.74 |
| 開市 | 49.84 |
| 買盤 | 55.35 |
| 賣出價 | 56.30 |
| 拍板 | 920.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 49.79 - 57.65 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 105 |
Barrons.comInsulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
Automated pumps are already used by about 40% of those with the autoimmune version of diabetes, known as Type-1.
ZacksNovo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion
Novo Nordisk (NVO) plans to invest $4.1 billion in order to expand its Clayton facility with a second manufacturing plant, boosting capacity for injectable treatments and creating 1,000 new jobs.
ZacksIs Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales of the blockbuster drug will rise further.
